Two case reports and a literature review of typical GBS and rare GBS variants associated with COVID-19

Orak S. A., Kubur Ç. Ç., Atasever A. K., POLAT M.

Archives de Pediatrie, vol.30, no.4, pp.236-239, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 4
  • Publication Date: 2023
  • Doi Number: 10.1016/j.arcped.2023.02.010
  • Journal Name: Archives de Pediatrie
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.236-239
  • Keywords: Child, Guillain -Barre syndrome, SARS-CoV-2, COVID-19, AMAN, Myasthenia gravis, Neurological complication, Autoimmune
  • Manisa Celal Bayar University Affiliated: Yes

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019, and is the infectious agent that caused the coronavirus disease 2019 (COVID-19) pandemic. Although respiratory and gastrointestinal manifestations of SARS-CoV-2 are well defined, the spectrum of neurological involvement is less defined. The classic type of Guillain–Barré syndrome (GBS) progresses over days to weeks and has a monophasic course. Areflexia/hyporeflexia and ascending and symmetrical paralysis are observed clinically in patients. It is an autoimmune process that typically leads to the destruction of myelin after infection. There have been numerous reports of adult patients with the coexistence of GBS disease and active COVID-19 illness, but this number is lacking for children. In this study, we present a literature review of the etiological correlation between SARS-CoV-2 and GBS and describe the cases of two pediatric patients with acute monophasic Guillain–Barré syndrome (GBS) during active COVID-19 infection.